Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner

Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner

JNJ and AbbVie both beat revenue expectations in Q1 2026, yet their strategies could not look more different, and which playbook actually wins depends entirely on what kind of investor you are.

Johnson & Johnson wins FDA approval for Dual Energy Platform

Johnson & Johnson has received US Food and Drug Administration approval for its Dual Energy THERMOCOOL SMARTTOUCH SF Platform, expanding treatment options for physicians performing catheter ablation procedures. The platform combines radiofrequency and pulsed field energy in a single catheter and is expected to begin a phased commercial rollout in the US later this summer. […] The post Johnson & Johnson wins FDA approval for Dual Energy Platform …